NSEGeneral Updates5d ago · 15 Oct 2026, 08:40 pm
General Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryESG
Mankind Pharma Limited has received an ESG rating of '71' from NSE Sustainability, a SEBI registered ESG Rating Provider, for FY26, based on publicly available information.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
MANKIND1_15102026204014_ESGRatingIntimation.pdf
View document text
October 15, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Environmental, Social and Governance (ESG) Rating
Ref.: Regulation 30 & 51 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”)
Pursuant to Regulations 30 and 51 of the Listing Regulations, we wish to inform you that NSE
Sustainability Ratings and Analytics Limited (“NSE Sustainability”), a SEBI registered ESG
Rating Provider, has assigned the Environmental, Social, and Governance (ESG) Rating of
‘71’ to the Company.
The Company has not engaged NSE Sustainability for the said rating, same has been
independently assigned by NSE Sustainability for FY26, based on publicly available
information.
The above disclosure is also being made available on the Company’s website at
www.mankindpharma.com.
This is for your information and records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer